glp 1 agonist dementia GLP-1 Medications Associated with Reduced Likelihood of Compared to Other Diabetic Meds Comparative dementia risk with GLP1

Despite the side effects and murky insurance coverage, GLP-1s are becoming more common weight loss interventions

In a study, scientists investigated the role of GLP- 1 and GIP on central cells in regulating body weight homeostasis [79]

Moreover, the results of cardiovascular outcome trials in persons with T2D given GLP-1RA demonstrating reduced stroke, myocardial infarction, and cardiovascular death 35 along with the emerging evidence demonstrating positive effects of GLP-1RAs 36,37 on kidney outcomes adds further impetus that these drugs have pleiotropic benefits

Please talk with your doctor about the risks and side effects before starting any GLP-1 medication